Analysts expect The Medicines Company's (Nasdaq: MDCO) inclisiran to outsell Esperion Therapeutics Inc.'s (Nasdaq: ESPR) bemepedoic acid. Shares of The Medicines Company soared $3.98 to close at $28.81 while Esperion stock added 73 cents to close at $77.93.
Medicines' inclisiran expected to outsell bemepedoic acid
January 22, 2018 at 16:22 PM EST